J&J CFO on Third-Quarter, Outlook, Consumer Spinoff

The transcript covers a discussion on the impact of a strong dollar on company growth, economic conditions, and inflation. It highlights the company's strategies to manage inflation and input costs, updates on the consumer spinoff, and future plans for Johnson & Johnson. The conversation also touches on the strategy for pharmaceuticals and Med tech growth, and insights into the COVID vaccine demand.

How has the company's growth performance changed from the second quarter to the third quarter?

What factors are contributing to the strength of the U.S. dollar according to the discussion?

What challenges is the company facing in terms of inflation and gross margins?

What is the company's outlook for the healthcare industry despite potential recession?

How does the company plan to address rising input costs and inflation?

What are the company's plans regarding the consumer health business spinoff?

What is the current status of the COVID vaccine demand according to the company?